Drug Shortage Report for ELELYSO
| Report ID | 233801 |
| Drug Identification Number | 02425637 |
| Brand name | ELELYSO |
| Common or Proper name | Elelyso |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TALIGLUCERASE ALFA |
| Strength(s) | 200UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1x10ml |
| ATC code | A16AB |
| ATC description | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-07-24 |
| Estimated end date | |
| Actual end date | 2025-05-08 |
| Shortage status | Resolved |
| Updated date | 2025-05-09 |
| Company comments | Product was discontinued |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2025-05-09 | French | Compare |
| v9 | 2025-05-09 | English | Compare |
| v8 | 2024-11-05 | French | Compare |
| v7 | 2024-11-05 | English | Compare |
| v6 | 2024-09-19 | French | Compare |
| v5 | 2024-09-19 | English | Compare |
| v4 | 2024-08-29 | French | Compare |
| v3 | 2024-08-29 | English | Compare |
| v2 | 2024-07-26 | French | Compare |
| v1 | 2024-07-26 | English | Compare |
Showing 1 to 10 of 10